MedTrace Logo

Green Tea Extract and Prostate Cancer

NCT00676780 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2012-08-08

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to see if a green tea extract can beneficially alter several markers of cancer risk and progression.

Conditions

Interventions

DRUG

Polyphenon E (EGCG)

4 capsules daily with a meal for the duration of the study

Sponsors & Collaborators

  • Polyphenon Pharma

    collaborator UNKNOWN

  • Louisiana State University Health Sciences Center Shreveport

    lead OTHER

Principal Investigators

  • Jerry W McLarty, Ph.D. · LSUHSC Shreveport

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-05-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00676780 on ClinicalTrials.gov